As a practicing physician who has cared for patients with Alzheimer’s disease and other dementias for more than two decades, ...
Health tech veteran Leo Grady believes the microbiome is going to revolutionize healthcare. | Leo Grady, the former CEO of ...
In addition to depression, the FDA has approved the use of TMS to treat obsessive-compulsive disorder (OCD) and migraines and for smoking cessation. Beyond those health concerns, TMS has also been ...
The global mental wellness market is anticipated to grow from USD 145.83 billion to USD 280.52 billion in 10 years. The market will experience rapid growth due to the rising awareness about mental ...
If you’re looking for a natural and effective alternative to prescription adderall medication, this guide is for you.
In the wake of enhanced efficiency demand and soaring competition, professionals and amateurs are exploring unconventional ways to boost cognitive processes. Everyone is in the race to improve brain ...
BrainSpec, the comprehensive software platform enabling virtual biopsies of the brain, has been awarded clearance by the FDA to begin using their Magnetic Resonance Spectroscopy (MRS) platform to ...
Dementia patients may be denied life-changing drugs by the NHS after a report concluded that the disease’s burden on families ...
Research done at St. Louis University School of Medicine as part of a national study helps lead to FDA approval of a new treatment for Alzheimer’s-associated agitation.
American mortality is at the youngest it has been in almost two decades. But could repurposing a decades-old diabetes drug ...
Loyal for Dogs is developing drugs to extend doggie lifespans. One drug just cleared a key FDA hurdle, a sign the agency is ready to take longevity seriously. The injection could be available in ...
Titled “Guidance for Industry, Alzheimer’s Disease: Developing Drugs for the Treatment of Early Stage Disease”, the draft guidance explains the FDA’s current thinking about the way ...
